Dr Reddy’s Sputnik Vaccine Gears Up for Phase 3 Clinical Trial

No Comments
Posted in Featured, National, Northeast

Dr. Reddy’s Laboratories announced that the Drugs Control General of India (DCGI) has given them the nod to conduct phase 3 clinical trial for the Sputnik V vaccine.

“This is an important milestone in the progress of this pivotal clinical trial of the vaccine. We expect to commence the phase 3 study within this month and will continue to fast-track our efforts to bring in a safe and efficacious vaccine for the Indian population”, the Co-chairman GV Prasad said.

Sputnik V was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against Covid-19 based on the established human adenoviral vector platform.

The vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials in Russia.

Tags: , ,

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The reCAPTCHA verification period has expired. Please reload the page.

More Articles